Biotron: Replacement Prospectus
Filed with ASX · · 43 pages · English
Summary by 6ix AI
Biotron Limited has filed a Replacement Prospectus for a renounceable pro rata offer to eligible shareholders, aiming to raise funds through the issuance of new shares. This prospectus replaces a previous one lodged with ASIC and provides essential information regarding the investment opportunity and associated risks. The offer is partially underwritten by Mahe Capital for a specified amount, which is intended to support the company's ongoing operations and development projects.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from Biotron
- Response to ASX Query Letter
- Supplementary Prospectus
- Response to ASX Aware Query
- Prospectus
- Renounceable Rights Issue
Later from Biotron
- Rights Issue Closed
- Full Year Statutory Accounts and Appendix 4E
- Pause in Trading
- Trading Halt
- Acquisition of Sedarex Limited and $2.5m capital raising
Follow Biotron into a list and get an email when it puts out news.
Follow Biotron